ArticleEuropean journal of heart failure2025

Rationale and design of the FAIR-HF2-DZHK05 trial: Ferric carboxymaltose assessment of morbidity and mortality in patients with iron deficiency and chronic heart failure.

Stefan D Anker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.